Community Health Systems (NYSE:CYH) shares traded 1.29% up during most recent session to reach at the closing price of $5.5. The stock exchanged hands 2.12 Million shares versus average trading capacity of 3.04 Million shares, yielding a market cap of $634.48 Million. Wall Street analysts covering the stock are projecting that the stock will reach $4.79 within the next 52-weeks. The mean target projections are based on 17 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Community Health Systems (NYSE:CYH) high price target of $7 and with a conservative view have low price target of $3.
Wells Fargo “Reinstates” Community Health Systems (NYSE:CYH) in a research note issued to investors on 1/30/18 to Underperform with price target of $4.5.
Additionally on 1/03/18 Goldman Sachs “Initiates Coverage On” Community Health Systems (NYSE:CYH) to Sell setting price target at $3 and on 12/14/17 JP Morgan “Downgrades” the stock to Underweight at $0. Furthermore on 11/03/17 Citigroup “Maintained” the stock to Neutral at $5.
On the other hand the company has Relative Strength Index (RSI 14) of 56.49 along with Average True Range (ATR 14) of 0.33, Consequently Community Health Systems (NYSE:CYH)’s weekly and monthly volatility is 6.90%, 6.46% respectively. The company’s beta value is at 1.29.
In terms of Buy, Sell or Hold recommendations, Community Health Systems (NYSE:CYH) has analysts’ mean recommendation of 3.4. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Community Health Systems (NYSE:CYH)’s minimum EPS for the current quarter is at $-0.63 and can go high up to $-0.14. The consensus mean EPS for the current quarter is at $-0.34 derived from a total of 18 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.46 earnings per share for the same quarter during last year.
Previously Community Health Systems (NYSE:CYH) reported $-0.77 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.3 by $-0.47. The company posted an earnings surprise of -156.7%.
While considering growth estimates of the company, it has next quarter growth estimates of -275% whereas during current quarter it has -173.9% estimations over growth, comparing to the estimations of -378.3% during current year and 30.5% for next year. Past 5 years growth of Community Health Systems (NYSE:CYH) observed at -25.6%, looking forward for the next 5 years it has a strong prediction of 6.1% over growth.
Community Health Systems (NYSE:CYH)’s revenue estimates for the current quarter are $3.53 Billion according to 16 number of analysts, for the current quarter the company has high revenue estimates of $3.59 Billion in contradiction of low revenue estimates of $3.37 Billion. For the current year the company’s revenue estimates are $15.83 Billion compared to low analyst estimates of $15.67 Billion and high estimates of $15.89 Billion according to 17 number of analysts.
Currently Community Health Systems (NYSE:CYH)’s shares owned by insiders are 0.4%, whereas shares owned by institutional owners are 0%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 2.57%.
Community Health Systems (NYSE:CYH) 52-week high price stands at $10.51 and low price stands at $3.85, its price distance from 52-week high is -47.67% while its distance from 52-week low price is 42.86%. The stock hit its 52-week high on 05/02/17, and 52-week low on 11/21/17.
Community Health Systems (NYSE:CYH)’s trailing twelve month revenues are $16.77 Billion, whereas its price to sales ratio for the same period is 0.04. Its book value per share for the most recent quarter is $10.84 while its price to book ratio for the same period is 0.51, as for as the company’s cash per share for the most recent quarter is $5.11, however its price to cash per share ratio for the same period is 1.08. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.